In vitro protein kinase assay

LH Luke D. Hutchinson
ND Nicola J. Darling
SN Stephanos Nicolaou
IG Ilaria Gori
DS Daniel R. Squair
PC Philip Cohen
CH Caroline S. Hill
GS Gopal P. Sapkota
ask Ask a question
Favorite

In all, 21-µL reaction solutions were prepared containing 200 ng of protein kinase and 2 µg of substrate protein in 1× kinase assay buffer (50 mM Tris-HCl, pH 7.5, 0.1 mM EGTA, 10 mM magnesium acetate, 0.1% (v/v) 2-mercaptoethanol and 0.1 mM [γ32P]-ATP). Reactions were conducted at 30 °C for 30 min at 1050 rpm and terminated via the addition of 7 µL of NuPAGE 4× LDS sample buffer containing 8% (v/v) 2-mercaptoethanol. For in vitro kinase assays involving the use of small-molecule inhibitors, reaction solutions containing all the required components were incubated at 30 °C for 10 min at 1050 rpm prior to the addition of 0.1 mM [γ32 P]-ATP. Reactions were then performed as detailed previously. Samples were incubated at 95 °C for 5 min, and subsequently centrifuged at 5.0 × 103 × g for 1 min. Samples were loaded onto NuPAGE 4–12% Bis-Tris precast polyacrylamide gels and resolved via SDS-PAGE. Polyacrylamide gels were subsequently stained with InstantBlue Coomassie Protein Stain (Expedeon) to visualise the resolved recombinant proteins, and imaged using the ChemiDoc Imaging System (Bio-Rad). 32P radioactivity was analysed via autoradiography using Amersham Hyperfilm (GE Healthcare Life Sciences).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A